ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors.

Julius Strauss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.